NRx Pharmaceuticals, Inc. (NRXP)

NASDAQ

$3.47

+$0.14 (4.20%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$3.33$3.55

Open $3.35

52 Week Range

$1.62$5.05

Previous Close $3.33

Market Cap59.98M

Volume521.83K

Avg Volume1.25M

P/E (TTM)-4.67

EPS (TTM)$-0.62

Dividend / YieldN/A

Dividend StreakN/A

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOJonathan C. Javitt

Employees29

Websitewww.nrxpharma.com

Trading Information

Open

$3.35

Previous Close

$3.33

Day High

$3.55

Day Low

$3.33

52 Week High

$5.05

52 Week Low

$1.62

About NRx Pharmaceuticals, Inc.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOJonathan C. Javitt

Employees29

Websitewww.nrxpharma.com

Trading Information

Open

$3.35

Previous Close

$3.33

Day High

$3.55

Day Low

$3.33

52 Week High

$5.05

52 Week Low

$1.62